|
|
| (2 intermediate revisions by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Esmolol#Adult Indications and Dosage]] |
| {{Esmolol}}
| |
| {{CMG}}; {{AE}} {{AZ}}
| |
| | |
| ==Indications And Usage==
| |
| | |
| ===Supraventricular Tachycardia or Noncompensatory Sinus Tachycardia===
| |
| *BREVIBLOC (Esmolol Hydrochloride) is indicated for the rapid control of ventricular rate in patients with [[atrial fibrillation]] or [[atrial flutter]]in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable.
| |
| *BREVIBLOC is also indicated in noncompensatory [[sinus tachycardia]] where, in the physician’s judgment, the rapid heart rate requires specific intervention.
| |
| *BREVIBLOC is intended for short-term use.
| |
| | |
| ===Intraoperative and Postoperative Tachycardia and/or Hypertension===
| |
| BREVIBLOC (Esmolol Hydrochloride) is indicated for the short-term treatment of [[tachycardia]] and [[hypertension]] that occur during induction and [[tracheal intubation]], during surgery, on emergence from [[anesthesia]] and in the postoperative period, when in the physician’s judgment such specific intervention is considered indicated.
| |
| | |
| Use of BREVIBLOC to prevent such events is not recommended.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
|
| |
|
| | [[Category:Beta blockers]] |
| | [[Category:Cardiovascular Drugs]] |
| [[Category:Drugs]] | | [[Category:Drugs]] |